Designing Paclitaxel Drug Delivery Systems Aimed at Improved  Patient Outcomes: Current Status and Challenges

<table>Structure of Paclitaxel (2<i>α</i>,4<i>α</i>,5<i>β</i>,7<i>β</i>,10<i>β</i>,13<i>α</i>)-4,10-bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,7-dihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate.</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Designing Paclitaxel Drug Delivery Systems Aimed at Improved  Patient Outcomes: Current Status and Challenges 